State Street Corp Kura Oncology, Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Kura Oncology, Inc. stock. As of the latest transaction made, State Street Corp holds 2,668,844 shares of KURA stock, worth $24 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,668,844
Previous 2,884,541 7.48%
Holding current value
$24 Million
Previous $59.4 Million 12.2%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$18.57 - $23.23 $4.01 Million - $5.01 Million
-215,697 Reduced 7.48%
2,668,844 $52.1 Million
Q2 2024

Aug 14, 2024
SELL
$17.53 - $22.98 $23.1 Million - $30.2 Million
-1,315,413 Reduced 31.32%
2,884,541 $59.4 Million
Q1 2024

May 15, 2024
BUY
$13.42 - $23.53 $17.2 Million - $30.1 Million
1,278,144 Added 43.74%
4,199,954 $89.6 Million
Q4 2023

Feb 14, 2024
SELL
$7.58 - $14.38 $2.54 Million - $4.81 Million
-334,777 Reduced 10.28%
2,921,810 $42 Million
Q3 2023

Nov 14, 2023
BUY
$8.44 - $11.86 $2.05 Million - $2.89 Million
243,439 Added 8.08%
3,256,587 $29.7 Million
Q2 2023

Aug 14, 2023
SELL
$9.62 - $13.99 $7.98 Million - $11.6 Million
-829,530 Reduced 21.59%
3,013,148 $31.9 Million
Q1 2023

May 15, 2023
SELL
$10.71 - $14.6 $6.47 Million - $8.81 Million
-603,749 Reduced 13.58%
3,842,678 $47 Million
Q4 2022

Feb 14, 2023
BUY
$11.23 - $16.9 $872,166 - $1.31 Million
77,664 Added 1.78%
4,446,427 $55.2 Million
Q3 2022

Nov 15, 2022
BUY
$12.01 - $19.45 $16.1 Million - $26 Million
1,337,149 Added 44.11%
4,368,763 $59.7 Million
Q2 2022

Aug 15, 2022
SELL
$10.71 - $18.33 $2.88 Million - $4.93 Million
-269,134 Reduced 8.15%
3,031,614 $55.6 Million
Q1 2022

May 16, 2022
SELL
$11.78 - $16.98 $911,713 - $1.31 Million
-77,395 Reduced 2.29%
3,300,748 $53.1 Million
Q4 2021

Feb 14, 2022
BUY
$12.22 - $19.57 $2.07 Million - $3.31 Million
169,034 Added 5.27%
3,378,143 $47.3 Million
Q3 2021

Nov 15, 2021
SELL
$15.42 - $21.72 $702,118 - $988,976
-45,533 Reduced 1.4%
3,209,109 $60.1 Million
Q2 2021

Aug 16, 2021
BUY
$20.85 - $29.88 $8.78 Million - $12.6 Million
420,992 Added 14.86%
3,254,642 $67.9 Million
Q1 2021

May 17, 2021
BUY
$24.75 - $39.14 $3.87 Million - $6.12 Million
156,430 Added 5.84%
2,833,650 $80.1 Million
Q4 2020

Feb 16, 2021
BUY
$29.0 - $41.62 $27.4 Million - $39.4 Million
946,021 Added 54.65%
2,677,220 $87.4 Million
Q3 2020

Nov 10, 2020
BUY
$16.3 - $30.64 $1.26 Million - $2.37 Million
77,498 Added 4.69%
1,731,199 $53 Million
Q2 2020

Aug 14, 2020
BUY
$7.95 - $18.81 $4.53 Million - $10.7 Million
569,974 Added 52.59%
1,653,701 $27 Million
Q1 2020

May 11, 2020
BUY
$6.45 - $14.04 $6.99 Million - $15.2 Million
1,083,727 New
1,083,727 $10.8 Million

Others Institutions Holding KURA

# of Institutions
185
Shares Held
81.8M
Call Options Held
42.1K
Put Options Held
34K
View Full List

About Kura Oncology, Inc.

KURA Quotes by TradingView
  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $603M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email